The FDA's clinical hold on Ortho RIT's Ortho-R drug has been lifted, according to a Dec. 13 news release.
Ortho RTI received a clinical hold letter for Ortho-R, a regenerative product for rotator cuff repairs in June.
After addressing concerns, the company was cleared to proceed with clinical trials for Ortho-R. Ortho RTI plans to enroll 78 patients across 10 clinical sites for the trial.